This report aims to provide a comprehensive presentation of the global market for Cancer Anorexia-Cachexia Syndrome Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Anorexia-Cachexia Syndrome Drug. This report contains market size and forecasts of Cancer Anorexia-Cachexia Syndrome Drug in global, including the following market information:
Global Cancer Anorexia-Cachexia Syndrome Drug Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Sales, 2018-2023, 2024-2032, (K Pcs)
Global top five Cancer Anorexia-Cachexia Syndrome Drug companies in 2022 (%)
The global Cancer Anorexia-Cachexia Syndrome Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
NEO-1940 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Anorexia-Cachexia Syndrome Drug include Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd and RaQualia Pharma Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Anorexia-Cachexia Syndrome Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Anorexia-Cachexia Syndrome Drug Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, by Type, 2022 (%)
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others
Global Cancer Anorexia-Cachexia Syndrome Drug Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Cancer Anorexia-Cachexia Syndrome Drug Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Anorexia-Cachexia Syndrome Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Anorexia-Cachexia Syndrome Drug revenues share in global market, 2022 (%)
Key companies Cancer Anorexia-Cachexia Syndrome Drug sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Cancer Anorexia-Cachexia Syndrome Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Anorexia-Cachexia Syndrome Drug, market overview.
Chapter 2: Global Cancer Anorexia-Cachexia Syndrome Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Anorexia-Cachexia Syndrome Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Anorexia-Cachexia Syndrome Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Anorexia-Cachexia Syndrome Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Anorexia-Cachexia Syndrome Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Anorexia-Cachexia Syndrome Drug Overall Market Size
2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size: 2022 VS 2030
2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales: 2018-2030
3 Company Landscape
3.1 Top Cancer Anorexia-Cachexia Syndrome Drug Players in Global Market
3.2 Top Global Cancer Anorexia-Cachexia Syndrome Drug Companies Ranked by Revenue
3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Companies
3.4 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Companies
3.5 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cancer Anorexia-Cachexia Syndrome Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Anorexia-Cachexia Syndrome Drug Players in Global Market
3.8.1 List of Global Tier 1 Cancer Anorexia-Cachexia Syndrome Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Anorexia-Cachexia Syndrome Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Markets, 2022 & 2030
4.1.2 NEO-1940
4.1.3 C-1889
4.1.4 DLN-101
4.1.5 Foxo1-nRNA
4.1.6 AVGN-7
4.1.7 Others
4.2 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue & Forecasts
4.2.1 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2023
4.2.2 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2024-2030
4.2.3 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
4.3 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales & Forecasts
4.3.1 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2023
4.3.2 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2024-2030
4.3.3 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
4.4 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue & Forecasts
5.2.1 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2023
5.2.2 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2024-2030
5.2.3 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
5.3 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales & Forecasts
5.3.1 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2023
5.3.2 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2024-2030
5.3.3 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
5.4 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2022 & 2030
6.2 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue & Forecasts
6.2.1 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2023
6.2.2 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2024-2030
6.2.3 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
6.3 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales & Forecasts
6.3.1 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2023
6.3.2 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2024-2030
6.3.3 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2030
6.4.2 By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2030
6.4.3 US Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.4.4 Canada Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.4.5 Mexico Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2030
6.5.2 By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2030
6.5.3 Germany Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.5.4 France Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.5.5 U.K. Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.5.6 Italy Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.5.7 Russia Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.5.8 Nordic Countries Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.5.9 Benelux Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2030
6.6.2 By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2030
6.6.3 China Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.6.4 Japan Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.6.5 South Korea Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.6.6 Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.6.7 India Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2030
6.7.2 By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2030
6.7.3 Brazil Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.7.4 Argentina Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales, 2018-2030
6.8.3 Turkey Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.8.4 Israel Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.8.5 Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
6.8.6 UAE Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Acacia Pharma Ltd
7.1.1 Acacia Pharma Ltd Company Summary
7.1.2 Acacia Pharma Ltd Business Overview
7.1.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.1.5 Acacia Pharma Ltd Key News & Latest Developments
7.2 Aeterna Zentaris Inc
7.2.1 Aeterna Zentaris Inc Company Summary
7.2.2 Aeterna Zentaris Inc Business Overview
7.2.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.2.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.2.5 Aeterna Zentaris Inc Key News & Latest Developments
7.3 Aphios Corp
7.3.1 Aphios Corp Company Summary
7.3.2 Aphios Corp Business Overview
7.3.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.3.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.3.5 Aphios Corp Key News & Latest Developments
7.4 Incyte Corp
7.4.1 Incyte Corp Company Summary
7.4.2 Incyte Corp Business Overview
7.4.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.4.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.4.5 Incyte Corp Key News & Latest Developments
7.5 Lakewood-Amedex Inc
7.5.1 Lakewood-Amedex Inc Company Summary
7.5.2 Lakewood-Amedex Inc Business Overview
7.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.5.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.5.5 Lakewood-Amedex Inc Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.6.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Obexia AG
7.7.1 Obexia AG Company Summary
7.7.2 Obexia AG Business Overview
7.7.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.7.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.7.5 Obexia AG Key News & Latest Developments
7.8 PsiOxus Therapeutics Ltd
7.8.1 PsiOxus Therapeutics Ltd Company Summary
7.8.2 PsiOxus Therapeutics Ltd Business Overview
7.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.8.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.8.5 PsiOxus Therapeutics Ltd Key News & Latest Developments
7.9 RaQualia Pharma Inc
7.9.1 RaQualia Pharma Inc Company Summary
7.9.2 RaQualia Pharma Inc Business Overview
7.9.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.9.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.9.5 RaQualia Pharma Inc Key News & Latest Developments
7.10 Viking Therapeutics Inc
7.10.1 Viking Therapeutics Inc Company Summary
7.10.2 Viking Therapeutics Inc Business Overview
7.10.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.10.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2018-2023)
7.10.5 Viking Therapeutics Inc Key News & Latest Developments
8 Global Cancer Anorexia-Cachexia Syndrome Drug Production Capacity, Analysis
8.1 Global Cancer Anorexia-Cachexia Syndrome Drug Production Capacity, 2018-2030
8.2 Cancer Anorexia-Cachexia Syndrome Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Anorexia-Cachexia Syndrome Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Anorexia-Cachexia Syndrome Drug Supply Chain Analysis
10.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Value Chain
10.2 Cancer Anorexia-Cachexia Syndrome Drug Upstream Market
10.3 Cancer Anorexia-Cachexia Syndrome Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Cancer Anorexia-Cachexia Syndrome Drug in Global Market
Table 2. Top Cancer Anorexia-Cachexia Syndrome Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Companies, 2018-2023
Table 5. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
Table 9. List of Global Tier 1 Cancer Anorexia-Cachexia Syndrome Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Anorexia-Cachexia Syndrome Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), 2024-2030
Table 26. By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales, (K Pcs), 2024-2030
Table 46. Acacia Pharma Ltd Company Summary
Table 47. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 48. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Acacia Pharma Ltd Key News & Latest Developments
Table 50. Aeterna Zentaris Inc Company Summary
Table 51. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 52. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Aeterna Zentaris Inc Key News & Latest Developments
Table 54. Aphios Corp Company Summary
Table 55. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 56. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Aphios Corp Key News & Latest Developments
Table 58. Incyte Corp Company Summary
Table 59. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 60. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Incyte Corp Key News & Latest Developments
Table 62. Lakewood-Amedex Inc Company Summary
Table 63. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 64. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Lakewood-Amedex Inc Key News & Latest Developments
Table 66. Novartis AG Company Summary
Table 67. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 68. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Novartis AG Key News & Latest Developments
Table 70. Obexia AG Company Summary
Table 71. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 72. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Obexia AG Key News & Latest Developments
Table 74. PsiOxus Therapeutics Ltd Company Summary
Table 75. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 76. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. PsiOxus Therapeutics Ltd Key News & Latest Developments
Table 78. RaQualia Pharma Inc Company Summary
Table 79. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 80. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. RaQualia Pharma Inc Key News & Latest Developments
Table 82. Viking Therapeutics Inc Company Summary
Table 83. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Offerings
Table 84. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Viking Therapeutics Inc Key News & Latest Developments
Table 86. Cancer Anorexia-Cachexia Syndrome Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 87. Global Cancer Anorexia-Cachexia Syndrome Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Cancer Anorexia-Cachexia Syndrome Drug Production by Region, 2018-2023 (K Pcs)
Table 89. Global Cancer Anorexia-Cachexia Syndrome Drug Production by Region, 2024-2030 (K Pcs)
Table 90. Cancer Anorexia-Cachexia Syndrome Drug Market Opportunities & Trends in Global Market
Table 91. Cancer Anorexia-Cachexia Syndrome Drug Market Drivers in Global Market
Table 92. Cancer Anorexia-Cachexia Syndrome Drug Market Restraints in Global Market
Table 93. Cancer Anorexia-Cachexia Syndrome Drug Raw Materials
Table 94. Cancer Anorexia-Cachexia Syndrome Drug Raw Materials Suppliers in Global Market
Table 95. Typical Cancer Anorexia-Cachexia Syndrome Drug Downstream
Table 96. Cancer Anorexia-Cachexia Syndrome Drug Downstream Clients in Global Market
Table 97. Cancer Anorexia-Cachexia Syndrome Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cancer Anorexia-Cachexia Syndrome Drug Segment by Type in 2022
Figure 2. Cancer Anorexia-Cachexia Syndrome Drug Segment by Application in 2022
Figure 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. Cancer Anorexia-Cachexia Syndrome Drug Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Anorexia-Cachexia Syndrome Drug Revenue in 2022
Figure 9. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 11. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 12. By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 15. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 16. By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 20. By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 21. By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 22. By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 23. US Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 28. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 29. France Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 37. China Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 41. India Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 43. By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 44. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2018-2030
Figure 48. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$, Mn), 2018-2030
Figure 52. Global Cancer Anorexia-Cachexia Syndrome Drug Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Cancer Anorexia-Cachexia Syndrome Drug by Region, 2022 VS 2030
Figure 54. Cancer Anorexia-Cachexia Syndrome Drug Industry Value Chain
Figure 55. Marketing Channels
